Atlas Venture Life Science Advisors, LLC Portfolio Holdings

Atlas Venture Life Science Advisors, LLC

  • $341 Million
  • Q1 2025

Atlas Venture Life Science Advisors, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $341 Million distributed in 13 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $134M, Dyne Therapeutics, Inc. with a value of $95.5M, Day One Biopharmaceuticals, Inc. with a value of $51M, Third Harmonic Bio, Inc. with a value of $36.1M, and Vigil Neuroscience, Inc. with a value of $10.4M.

Examining the 13F form we can see an decrease of $265M in the current position value, from $606M to 341M.

Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $341 Million
Healthcare: $341 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.61B
$134 Million 39.25% of portfolio
4,896,462
Q3 2024 Reduced 8.48%
$737M
$95.5 Million 27.97% of portfolio
9,130,465
Q1 2025 Added 13.86%
$511M
$51 Million 14.93% of portfolio
6,430,257
Q1 2024 Reduced 15.48%
$210M
$36.1 Million 10.57% of portfolio
10,402,286
Q4 2024 Reduced 4.63%
$224M
$10.4 Million 3.04% of portfolio
5,836,874
Q1 2022 New
$50.8M
$6.42 Million 1.88% of portfolio
5,018,178
Q4 2021 New
$65.5M
$4.52 Million 1.32% of portfolio
1,799,232
Q2 2024 Reduced 11.77%
$22.4M
$3.31 Million 0.97% of portfolio
8,279,484
Q1 2023 Added 0.01%
$92.6M
$219,000 0.06% of portfolio
305,255
Q4 2024 Reduced 24.23%
Disc Medicine, Inc.
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 4.98%
Q32 Bio, Inc.
-
$0 0.0% of portfolio
-
Q1 2024 New
Sionna Therapeutics, Inc.
-
$0 0.0% of portfolio
-
Q1 2025 New
Korro Bio, Inc.
-
$0 0.0% of portfolio
-
Q2 2024 Added 1.6%

Summary

  • Portfolio
  • No. of Stocks 13
  • Current Value $341 Million
  • Prior Value $606 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email